Basepoint Wealth’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Basepoint Wealth's ELV Position: Q1 2026 in Review
Basepoint Wealth increased its Elevance Health (ELV) stake by 0.38% in Q1 2026, buying an estimated $986 and bringing the position to 796 shares worth $233K. The position accounts for 0.13% of the portfolio, ranked #93.
Basepoint Wealth first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $914K in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Basepoint Wealth held 796 shares of Elevance Health worth $233K as of Q1 2026.
- Basepoint Wealth bought 3 Elevance Health shares in Q1 2026, an estimated $986.
- Elevance Health made up 0.13% of Basepoint Wealth's portfolio in Q1 2026, its #93 holding.
- Basepoint Wealth first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
- Basepoint Wealth's Elevance Health position peaked at $914K in Q4 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.